Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice

Watch this on-demand webcast from a live webinar where 3 experts discuss the latest data for the management of patients with relapsed or refractory myeloma, including new data from ASCO 2021.

Paul G. Richardson, MD
Program Director Nina Shah, MD Peter M. Voorhees, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: July 9, 2021 Expired: No longer available for credit

Download this slideset based on the content from a live-stream CCO series from Paul G. Richardson on treatment options for patients with relapsed/refractory multiple myeloma who have relapsed after first-line therapy.

Paul G. Richardson, MD
Program Director Released: June 23, 2021

Download this slideset based on the content from a live-stream CCO series from Peter M. Voorhees, MD on treatment options for patients with relapsed/refractory multiple myeloma who have relapsed after multiple lines of therapy.

Peter M. Voorhees, MD Released: June 24, 2021

Download this slideset based on the content from a live-stream CCO series from Nina Shah, MD on novel therapies under investigation for patients with relapsed/refractory multiple myeloma, including CAR T-cell therapies, bispecific antibodies, antibody drug conjugates, and CELMoDs.

Nina Shah, MD Released: June 24, 2021

Gain key clinical insights fast, with this short summary slideset from CCO on key considerations for optimal treatment selection for patients with relapsed/refractory myeloma.

Paul G. Richardson, MD
Program Director Nina Shah, MD Peter M. Voorhees, MD Released: June 25, 2021

The treatment landscape for multiple myeloma is rapidly evolving. Read how expert faculty choose and sequence therapy for patients with relapsed/refractory multiple myeloma to improve patient outcomes.

Paul G. Richardson, MD
Program Director Nina Shah, MD Peter M. Voorhees, MD Released: August 19, 2021

Listen to Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, as they answer audience questions from a live webinar about how to best use the plethora of active agents and regimens now available for patients with advanced multiple myeloma.

Paul G. Richardson, MD
Program Director Nina Shah, MD Peter M. Voorhees, MD Released: August 24, 2021

Download this short summary of key takeaways from a podcast on managing patients with R/R MM including expert recommendations on selecting optimal therapy.

Paul G. Richardson, MD Nina Shah, MD Peter M. Voorhees, MD Released: August 25, 2021